Biontech

Factory Renovation Delays European Union's Pfizer Vaccine Deliveries By 3-4 Weeks

World News | Agence France-Presse | Friday January 15, 2021

Deliveries of the coronavirus vaccine developed by BioNTech and Pfizer to EU nations will be delayed in the coming weeks because of works at the US pharma firm's plant in Belgium, Germany's health ministry said Friday.

Serum Institute Awaits WHO Emergency Approval For AstraZeneca Shot Soon

Business | Edited by Nirmalya Sen | Thursday January 14, 2021

The World Health Organization (WHO) listed Pfizer and BioNTech's Covid-19 shot for emergency use on December 31 as it sought to accelerate vaccination in the developing world, which is badly lagging Western countries

"Can Deliver Approximately 2 Billion Doses In 2021": German Firm BioNTech

World News | Agence France-Presse | Monday January 11, 2021

German company BioNTech, which developed the first coronavirus vaccine approved in the West, said Monday it expects to produce 2 billion doses in 2021, up from the previous forecast of 1.3 billion doses.

UK Approves Moderna's COVID Vaccine, To Purchase Another 10 Million Doses

World News | Reuters | Friday January 8, 2021

Britain's medical regulator on Friday approved Moderna's COVID-19 vaccine for use, the health ministry said, adding that it had agreed to purchase an additional 10 million doses of the shot as it eyed a spring rollout of the shot.

Vaccine "Neutralises" Key Mutation In UK, South Africa Virus Strains: BioNTech

World News | Agence France-Presse | Friday January 8, 2021

German company BioNTech said Friday a preliminary study shows that its vaccine works against the key mutation in coronavirus variants uncovered in Britain and South Africa.

European Union Doubles BioNTech-Pfizer Vaccine Order To 600 Million Doses

World News | Agence France-Presse | Friday January 8, 2021

The EU has struck a deal to double its supply of the BioNTech/Pfizer vaccine against Covid-19 to a total of 600 million doses, European Commission chief Ursula von der Leyen said on Friday.

Pfizer Says Its Vaccine Appears Effective Against New Coronavirus Variant

World News | Reuters | Friday January 8, 2021

Pfizer Inc and BioNTech's COVID-19 vaccine appeared to work against a key mutation in the highly transmissible new variants of the coronavirus discovered in the UK and South Africa, according to a laboratory study conducted by the U.S. drugmaker.

WHO Europe Urges "Safe Compromise" On Timing Of Covid Vaccine Doses

World News | Reuters | Thursday January 7, 2021

European countries rolling out the Pfizer-BioNTech COVID-19 vaccine should be flexible on the time between the first and second doses, the World Health Organization's director for the region said on Thursday.

WHO Recommends 2 Doses Of Pfizer Covid Vaccine Within 21-28 Days

World News | Reuters | Tuesday January 5, 2021

COVID-19 patients should take two doses of the new Pfizer/BioNTech vaccine within a period of 21-28 days, the head of the World Health Organization's immunization advisory group said on Tuesday.

No Evidence Covid Vaccine Will Work If Booster Dose Delayed: BioNTech

World News | Reuters | Monday January 4, 2021

BioNTech and partner Pfizer warned on Monday that they had no evidence that their jointly developed vaccine will continue to protect against COVID-19 if the booster shot is given later than tested in trials.

Bulgaria Reports 4 Cases Of Side Effects From Pfizer Covid Vaccine

World News | ANI | Monday January 4, 2021

Four Bulgarians vaccinated against COVID-19 with the Pfizer/BioNTech vaccine developed mild to moderate side effects, Bulgarian Drug Agency executive director Bogdan Kirilov said on Monday.

Will Mix Different Covid Vaccine Doses If Needed, Says UK

World News | Reuters | Saturday January 2, 2021

Britain will allow people to be given shots of different COVID-19 vaccines on rare occasions, despite a lack of evidence about the extent of immunity offered by mixing doses.

Pfizer And BioNtech To Offer Covid Vaccine To Volunteers Who Got Placebo

World News | Reuters | Saturday January 2, 2021

Pfizer Inc and its partner BioNTech Se plan to give volunteers who received a placebo in its COVID-19 vaccine trial an option to receive a first dose of the vaccine by March 1, 2021, while staying within the study.

BioNtech Founders Warn Of Covid Vaccine Supply Gaps: Report

World News | Reuters | Friday January 1, 2021

BioNTech is working flat out with partner Pfizer to boost production of their COVID-19 vaccine, its founders said, warning there would be gaps in supply until other vaccines were rolled out.

US Nurse Tests Positive Over A Week After Receiving Pfizer Vaccine: Report

World News | Reuters | Thursday December 31, 2020

A 45-year-old nurse in California tested positive for COVID-19 more than a week after receiving Pfizer Inc's coronavirus vaccine, an ABC News affiliate reported on Tuesday.